D Rondelaud1, G Dreyfuss, P Vignoles. 1. UPRES EA n(o) 3174/USC Inra, Facultés de Médecine et de Pharmacie, 87025 Limoges, France. daniel.rondelaud@unilim.fr <daniel.rondelaud@unilim.fr>
Abstract
OBJECTIVE: The aim of this communication was to report clinical disorders and biological abnormalities in patients followed over a 3- to 18-year period after the last date of fasciolosis treatment. These observations were noted in 87 individuals (out of 711) during a 30-year epidemiological survey. RESULTS: We noted diffuse pain in the right hypochondrium, persisting 2 to 6 years after treatment (3.7% of persons), and weight loss appearing during treatment and persisting afterwards (2.1%). CONCLUSIONS: Our current state of knowledge leads us to asking whether pain in the right hypochondrium and weight loss would not be due to the presence of persistent hepatic lesions following fasciolosis treatment. Other investigations in patients after treated fasciolosis are necessary to confirm these abnormalities and determine their frequency.
OBJECTIVE: The aim of this communication was to report clinical disorders and biological abnormalities in patients followed over a 3- to 18-year period after the last date of fasciolosis treatment. These observations were noted in 87 individuals (out of 711) during a 30-year epidemiological survey. RESULTS: We noted diffuse pain in the right hypochondrium, persisting 2 to 6 years after treatment (3.7% of persons), and weight loss appearing during treatment and persisting afterwards (2.1%). CONCLUSIONS: Our current state of knowledge leads us to asking whether pain in the right hypochondrium and weight loss would not be due to the presence of persistent hepatic lesions following fasciolosis treatment. Other investigations in patients after treated fasciolosis are necessary to confirm these abnormalities and determine their frequency.
Authors: María Adela Valero; María Victoria Periago; Ignacio Pérez-Crespo; René Angles; Fidel Villegas; Carlos Aguirre; Wilma Strauss; José R Espinoza; Patricia Herrera; Angelica Terashima; Hugo Tamayo; Dirk Engels; Albis Francesco Gabrielli; Santiago Mas-Coma Journal: PLoS Negl Trop Dis Date: 2012-09-13
Authors: René Angles; Paola Buchon; M Adela Valero; M Dolores Bargues; Santiago Mas-Coma Journal: Int J Environ Res Public Health Date: 2022-01-20 Impact factor: 3.390
Authors: María Dolores Bargues; Ali Halajian; Patricio Artigas; Wilmien J Luus-Powell; M Adela Valero; Santiago Mas-Coma Journal: Front Vet Sci Date: 2022-09-09